Conclusions: Primary series vaccination with BNT162b2 and BBIBP-CorV was effective at preventing COVID-19 among HCWs, most of whom had previous infection, during a period of mainly Delta circulation. Our results support the utility of COVID-19 primary vaccine series, a...
CDC polling on the new shotsaskedAmericans simply if they were open to getting the "new, updated COVID-19 vaccine." But the word "booster" still remains on many other official pages, including the United Kingdom's"autumn vaccine booster"campaign overseas and press releases within the U.S. ...
Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5-11 years by two-thirds during the Omicron ...
The study found that 60 percent of all adult COVID-19 deaths since June last year could have been prevented with "primary series" vaccination, two doses of Moderna or Pfizer or one dose of the Johnson & Johnson vaccine. The research used data from the U.S. Centers for Disease Control a...
Factors motivating the decision to vaccinate changed from safety-related concerns for the primary series to perceived need for the booster. It is key to address economic and health access barriers to achieve equitable COVID-19 vaccine uptake and continued protection against COVID-19. 展开 ...
six months post- vaccination, from 83.2% to 53.5%. We conclude that the 2-dose mRNA vaccine series initially offers strong protection against general SARS-CoV-2 infection caused by the delta variant in young adults, but protection substantially decreases over time. These findings indicate that vac...
Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with a purple cap is authorized for use to provide: • a 2-dose primary series to individuals 12 years of age and older; and • a third primary series dose to individuals 12 years of age and older with certain kind...
Although 42% of the world population has not completed the full vaccine primary series up to this date46, additional booster doses of vaccine are being rolled out in many places. Neutralization activity after the booster can be restored to a higher level for a short period of time. BNT162b2...
Now, they are planning a multicenter, randomized, double-blind, parallel-controlled efficacy trial of the inhaled vaccine as a booster dose following a primary series of immunization with Ad5-nCoV in Mexico.■
Pediatric COVID-19 vaccines: CDC's recommendations for Pfizer-BioNTech COVID-19 vaccine primary series in children 5–11 years old https://tceols.cdc.gov/ (2021) Google Scholar CDC, 2022 CDC Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the Unite...